Effect of Nutritional Management on RIOM in Patients With Advanced Head and Neck Cancer
A Prospective Single-arm Cohort Study on the Effect of Peri-radiotherapy Nutrition Management on Radiation-induced Oral Mucositis in Patients With Advanced Head and Neck Cancer
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
The goal of this clinical trial is to learn about the effect of nutritional management on radiation-induced oral mucositis in patients with advanced head and neck cancer during the peri-radiotherapy period . The main questions it aims to answer are:
- \[question 1\]Whether whole-course nutritional intervention can improve radiation-induced oral mucositis in patients with HNC.
- \[question 2\]Whether whole-course nutritional intervention can improve nutritional status and inflammation. Participants will be treated according to the NCCN guidelines. In addition, clinical pharmacists and registered dietitians provided nutritional intervention strategies based on clinical and nutritional assessments for the patients in the peri-radiotherapy nutrition group. Researchers will compare clinical routine examination and nutritional indicators between the standard treatment group and the peri-radiotherapy nutrition management group to see if nutrition management effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable head-and-neck-cancer
Started Mar 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2023
CompletedFirst Posted
Study publicly available on registry
February 10, 2023
CompletedStudy Start
First participant enrolled
March 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFebruary 10, 2023
February 1, 2023
2.8 years
January 18, 2023
February 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Degree of radiation-induced oral mucositis (RTOG criteria)
The Radiation Oncology Group (RTOG) grade of acute radiation injury was used for evaluation, which was divided into 0 to Ⅳ grades. The mild grade included 0, Ⅰ, and Ⅱgrades (grade 0 was no mucosal response; GradeⅠ: erythema, mild pain; GradeⅡ: spotty mucositis with serous exudation), severe grade Ⅲ- IV (Ⅲ: patchy fibrous mucositis with severe pain; Grade IV: necrosis, ulcer, hemorrhage).
six months
Study Arms (1)
Peri-radiotherapy nutrition management group
OTHERNutritional management was performed by clinical pharmacists and registered dietitians to develop nutritional intervention strategies based on patient clinical assessment and nutritional assessment. PG-SGA score was 0-3 points, and diet guidance was given. PG-SGA score \> 4 points, artificial nutrition intervention was carried out, and the way and amount of nutritional intervention were clarified to achieve the final daily energy and protein target requirements. Nutritional interventions and assessments were adjusted over time.
Interventions
Nutritional management was performed by clinical pharmacists and registered dietitians to develop nutritional intervention strategies based on patient clinical assessment and nutritional assessment. PG-SGA score was 0-3 points, and diet guidance was given. PG-SGA score \> 4 points, artificial nutrition intervention was carried out, and the way and amount of nutritional intervention were clarified to achieve the final daily energy and protein target requirements. Nutritional interventions and assessments were adjusted over time.
Eligibility Criteria
You may qualify if:
- Aged between 18 and 80 years old
- Advanced head and neck cancer (III-IV inoperable) is clearly diagnosed
- Predicted survival time \> 3 months
- Radical radiotherapy combined with chemotherapy or immunotherapy was performed in our hospital
- The patient has clear consciousness and no communication disorder
- Informed consent and voluntary participation in this study
You may not qualify if:
- Patients with previous surgery or radiotherapy for head and neck cancer
- Patients with concurrent or previous history of other tumors
- Distant metastasis
- Patients with allergy, intolerance or contraindication to enteral nutrition or parenteral nutrition
- Severe renal insufficiency (eGFR\<30ml/min/1.73m2)
- Combined with poorly controlled metabolic diseases such as diabetes
- Doctors or researchers deem that they are not suitable to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jing Yanlead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Chief Physician/Deputy Administrative Director of Oncology Department, Nanjing Drum Tower Hospital
Study Record Dates
First Submitted
January 18, 2023
First Posted
February 10, 2023
Study Start
March 1, 2023
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
February 10, 2023
Record last verified: 2023-02